Hengrui Pharma (Hengrui), a global pharmaceutical company focused on scientific and technological innovation, and Kailera Therapeutics, Inc. (Kailera), a clinical-stage biopharmaceutical company ...

However, a new drug may finally change all that. Veradermics, a Connecticut-based biopharmaceutical company, is developing a ...

"ESMO 2025: MSD’s ADC leapfrogs to Phase III in colorectal cancer " was originally created and published by Clinical Trials ...

Eight finalists will compete in November for the first Sleep Medicine Disruptors Innovation Award from the American Academy of Sleep Medicine (AASM).

These Phase III results could enhance uptake of Eli Lilly's Verzenio alongside ET in the adjuvant breast cancer setting, if ...

Updated Phase 1 givastomig monotherapy data show an impressive 18% ORR in metastatic gastric cancer patients who had received at least two prior ...

If educators do not learn to embrace AI, they risk being left behind. Yet the question before professional military education ...

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT ...

Updated: 5:02 pm October 20 The Oregon Attorney General's Office is calling for a review by a full appeals court after the US ...

Ntsako Mabunda showcased Tsonga culture at the National Oral History Conference, celebrating women’s role in preserving tradition.